Medical News

Beta-blockers Lowers Risk of Decompensation in Patients with Cirrhosis and Clinically Significant Portal Hypertension

A recent study on β blockers to prevent decompensation of cirrhosis with portal hypertension (PREDESCI) showed that long-term treatment with non-...

05 Apr, 2019

Email this page
PPA, Combined Measurement of Pre-portal Pressure Gradient and Albumin Helpful in Predicting Ascites Post Transjugular Intrahepatic Portosystemic Shunt

A retrospective study demonstrated the utility of combined measurement of pre-portal pressure gradient (pre-PPG) and albumin, defined as PPA, in...

02 Apr, 2019

Email this page
Benefits of Late-Evening Snacks on Liver Function in Patients with Cirrhosis

Eating late-evening snacks (LES) exerts beneficial effects on the liver function in patients with liver cirrhosis (LC), with or without...

28 Mar, 2019

Email this page
Anticoagulation Therapy: Safe and Effective in Cirrhosis and Portal Vein Thrombosis Patients

Anticoagulant therapy (AT) did not have an impact on the overall orthotopic liver transplant (OLT)-free survival in patients with cirrhosis and...

14 Mar, 2019

Email this page

Slide Library

Probiotics-Lactobacillus rhamnosus GG

This slide set covers basic understanding of probiotics and mechanism of action focussing on Lactobacillus rhamnosus GG strain.  

Email this page
Prucalopride (PRUCAPLA)

Treatment for chronic constipation has evolved with the advent of newer targeted therapies. Prucalopride is the first, selective and specific...

Email this page
Functional Dyspepsia

This slide set covers the basics of pathophysiology and treatment for functional dyspepsia, which is defined as per the Rome III criteria.  

Email this page
Celiac Disease: An Overview

Celiac disease is one of the most prevalent digestive conditions. Diagnosis requires strict criteria with a life-long gluten-free diet that needs to...

Email this page

Our Publications

UTI Management: For Gastroenterologists

Guidelines for UTI management, summarised for gastroenterologists.

Liver Disease and Pregnancy

Up to 3% of pregnant women suffer from pregnancy-associated liver diseases, which are the most frequent cause of liver dysfunction in pregnancy. Due...

Approach to Hepatitis B in Pregnancy

Chronic hepatitis B virus (HBV) infection in pregnancy is an important global health problem. Over 50% of the estimated 240–350 million chronic...

Diagnosis of Gastroesophageal Reflux Disease

Gastroesophageal reflux disease (GERD) is a disease which encompasses a wide range of symptoms for the patient. The diagnosis of GERD is often based...

Key Trials

Superior Outcomes with Midodrine Combined with Standard Medical Therapy in Cirrhotic Patients with Refractory Ascites

Long-term administration of midodrine along with standard medical therapy improves the systemic hemodynamics without any renal or hepatic...

Midodrine Superior to Octreotide in Improving the Hemodynamic Status of Cirrhosis Patients with Ascites

The study demonstrated a significantly greater improvement in plasma renin activity and eGFR with oral midodrine vs. octreotide in cirrhosis...

Short Term Proton Pump Inhibitor Use Can Increase Risk of Hip Fracture in Elderly Alzheimer Patients

The results of the study revealed that long-term or cumulative PPI use was not associated with an increased risk of hip fracture in community-...

Cessation of Nucleos(t)ide Analogue Therapy after HBeAg Seroconversion Might Be Associated with High Relapse Rates and Fatal Outcomes

Cessation of nucleos(t)ide analogue therapy in Caucasian patients after HBeAg seroconversion was associated with high relapse rates in more than 50...


Which of the following do you perceive to be the biggest USP of sofosbuvir-velpatasvir over other existing treatment options for chronic hepatitis C in India?
Its approval for use in decompensated HCV patients
33% (1 vote)
First fixed dose combination with pangenotypic activity
0% (0 votes)
No need of ribavirin addition for treating HCV genotype 3 patients
33% (1 vote)
All of the above
33% (1 vote)
Total votes: 3